Skip to main content
Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4506 ISIN · JP3495000006 LEI · 529900D60UKVYLJ2OJ79 T Manufacturing
Open in API
Filings indexed 94 across all filing types
Latest filing 2016-08-05 Interim / Quarterly Rep…
Country JP Japan
Listing T 4506

About Sumitomo Pharma Co., Ltd.

https://www.sumitomo-pharma.com/

Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.

Recent filings

Filing Released Lang Actions
四半期報告書－第197期第1四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, including the balance sheet, for the first quarter of the 197th fiscal period (April 1, 2016, to June 30, 2016). It includes management analysis, business risks, and auditor review information. This fits the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-08-05 Japanese
有価証券報告書－第196期(2015/04/01－2016/03/31)
Annual Report
2016-06-23 Japanese
四半期報告書－第196期第3四半期(2015/10/01－2015/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Sumitomo Dainippon Pharma Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis of financial conditions, and operational results for the third quarter of the 196th fiscal period. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2016
2016-02-05 Japanese
四半期報告書－第196期第2四半期(2015/07/01－2015/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the reference to the Financial Instruments and Exchange Act. It contains comprehensive financial data, including consolidated financial statements, management analysis of financial results, and details on business operations for the second quarter of the 196th fiscal period. It is not an announcement or a certification, but the full report itself, fitting the definition of an Interim/Quarterly Report (IR). H1 2016
2015-11-06 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.